Ortaleza, Ervie, Jr. E.

HRN: 21-59-08  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/20/2022
CEFTRIAXONE 1G (VIAL)
07/20/2022
07/27/2022
IV
1g
Q12h
Fracture
Waiting Final Action 
07/20/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
07/20/2022
07/27/2022
IV
600mg
Q6h
Fracture
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: